Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017.

Hampel B, Kusejko K, Kouyos RD, Böni J, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule P, Nicca D, Schmidt AJ, Nguyen H, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Braun DL, Fehr J; Swiss HIV Cohort Study group.

HIV Med. 2019 Dec 18. doi: 10.1111/hiv.12821. [Epub ahead of print]

PMID:
31849182
2.

Screening HIV-positive men who have sex with men for hepatitis C re-infection risk: is a single question on condom-use enough? A sensitivity analysis.

Künzler-Heule P, Engberg S, Battegay M, Schmidt AJ, Fierz K, Nguyen H, Kocher A, Nöstlinger C, Hampel B, Stöckle M, Béguelin C, Delaloye J, Schmid P, Flepp M, Rougement M, Braun DL, Fehr J, Nicca D; Swiss HIV Cohort Study (SHCS).

BMC Infect Dis. 2019 Sep 18;19(1):821. doi: 10.1186/s12879-019-4456-7.

3.

A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 With Coinfections, Noncommunicable Diseases, and Opportunistic Diseases.

Kusejko K, Bachmann N, Chaudron SE, Nguyen H, Braun DL, Hampel B, Battegay M, Bernasconi E, Calmy A, Cavassini M, Hoffmann M, Böni J, Yerly S, Klimkait T, Perreau M, Rauch A, Günthard HF, Kouyos RD; Swiss HIV Cohort Study .

J Infect Dis. 2019 Jun 19;220(2):244-253. doi: 10.1093/infdis/jiz093.

PMID:
30835292
4.

Noninferiority of Simplified Dolutegravir Monotherapy Compared to Continued Combination Antiretroviral Therapy That Was Initiated During Primary Human Immunodeficiency Virus Infection: A Randomized, Controlled, Multisite, Open-label, Noninferiority Trial.

Braun DL, Turk T, Tschumi F, Grube C, Hampel B, Depmeier C, Schreiber PW, Brugger SD, Greiner M, Steffens D, De Torrenté-Bayard C, Courlet P, Neumann K, Kuster H, Flepp M, Bertisch B, Decosterd L, Böni J, Metzner KJ, Kouyos RD, Günthard HF.

Clin Infect Dis. 2019 Oct 15;69(9):1489-1497. doi: 10.1093/cid/ciy1131.

PMID:
30601950
5.

High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men.

Braun DL, Hampel B, Martin E, Kouyos R, Kusejko K, Grube C, Flepp M, Stöckle M, Conen A, Béguelin C, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS; Swiss HIV Cohort Study.

Clin Infect Dis. 2019 Feb 1;68(4):561-568. doi: 10.1093/cid/ciy545.

PMID:
30107494
6.

High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men.

Braun DL, Hampel B, Kouyos R, Nguyen H, Shah C, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule P, Nicca D, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS; Swiss HIV Cohort Study.

Clin Infect Dis. 2019 Feb 1;68(4):569-576. doi: 10.1093/cid/ciy547.

PMID:
30107485
7.

Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland.

Kusejko K, Marzel A, Hampel B, Bachmann N, Nguyen H, Fehr J, Braun DL, Battegay M, Bernasconi E, Calmy A, Cavassini M, Hoffmann M, Böni J, Yerly S, Klimkait T, Perreau M, Rauch A, Günthard HF, Kouyos RD; Swiss HIV Cohort Study.

HIV Med. 2018 Nov;19(10):688-697. doi: 10.1111/hiv.12660. Epub 2018 Jul 26.

PMID:
30051600
8.

HIV pre-exposure prophylaxis (PrEP): Is it time to rethink HIV prevention in travelers?

Hampel B, Reinacher M, Fehr JS.

Travel Med Infect Dis. 2018 Sep - Oct;25:6-7. doi: 10.1016/j.tmaid.2018.06.008. Epub 2018 Jun 19. No abstract available.

PMID:
29929002
9.

The Sense of Smell Impacts Metabolic Health and Obesity.

Riera CE, Tsaousidou E, Halloran J, Follett P, Hahn O, Pereira MMA, Ruud LE, Alber J, Tharp K, Anderson CM, Brönneke H, Hampel B, Filho CDM, Stahl A, Brüning JC, Dillin A.

Cell Metab. 2017 Jul 5;26(1):198-211.e5. doi: 10.1016/j.cmet.2017.06.015.

10.

Assessing the need for a pre-exposure prophylaxis programme using the social media app Grindr®.

Hampel B, Kusejko K, Braun DL, Harrison-Quintana J, Kouyos R, Fehr J.

HIV Med. 2017 Nov;18(10):772-776. doi: 10.1111/hiv.12521. Epub 2017 May 19.

11.

Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity.

Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, Karsenty G, Brüning JC.

Cell. 2016 Aug 25;166(5):1338-1340. doi: 10.1016/j.cell.2016.08.010. No abstract available.

12.

Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity.

Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, Karsenty G, Brüning JC.

Cell. 2016 May 5;165(4):882-95. doi: 10.1016/j.cell.2016.03.033. Epub 2016 Apr 28. Erratum in: Cell. 2016 Aug 25;166(5):1338-1340.

13.

[CME. Eosinophilia - is a worm responsible?].

Hampel B, Beck BR, Rampini SK.

Praxis (Bern 1994). 2016 Mar 30;105(7):365-71; quiz 372-3. doi: 10.1024/1661-8157/a002291. Review. German. No abstract available.

PMID:
27005729
14.

Distinct Roles for JNK and IKK Activation in Agouti-Related Peptide Neurons in the Development of Obesity and Insulin Resistance.

Tsaousidou E, Paeger L, Belgardt BF, Pal M, Wunderlich CM, Brönneke H, Collienne U, Hampel B, Wunderlich FT, Schmidt-Supprian M, Kloppenburg P, Brüning JC.

Cell Rep. 2014 Nov 20;9(4):1495-506. doi: 10.1016/j.celrep.2014.10.045. Epub 2014 Nov 13.

15.

Neonatal insulin action impairs hypothalamic neurocircuit formation in response to maternal high-fat feeding.

Vogt MC, Paeger L, Hess S, Steculorum SM, Awazawa M, Hampel B, Neupert S, Nicholls HT, Mauer J, Hausen AC, Predel R, Kloppenburg P, Horvath TL, Brüning JC.

Cell. 2014 Jan 30;156(3):495-509. doi: 10.1016/j.cell.2014.01.008. Epub 2014 Jan 23.

16.

K(ATP)-channel-dependent regulation of catecholaminergic neurons controls BAT sympathetic nerve activity and energy homeostasis.

Tovar S, Paeger L, Hess S, Morgan DA, Hausen AC, Brönneke HS, Hampel B, Ackermann PJ, Evers N, Büning H, Wunderlich FT, Rahmouni K, Kloppenburg P, Brüning JC.

Cell Metab. 2013 Sep 3;18(3):445-55. doi: 10.1016/j.cmet.2013.08.006.

17.

Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study.

De Waele JJ, Tellado JM, Alder J, Reimnitz P, Jensen M, Hampel B, Arvis P.

Int J Antimicrob Agents. 2013 Jan;41(1):57-64. doi: 10.1016/j.ijantimicag.2012.08.013. Epub 2012 Nov 13.

18.

Acute selective ablation of rat insulin promoter-expressing (RIPHER) neurons defines their orexigenic nature.

Rother E, Belgardt BF, Tsaousidou E, Hampel B, Waisman A, Myers MG Jr, Brüning JC.

Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18132-7. doi: 10.1073/pnas.1206147109. Epub 2012 Oct 11.

19.

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study.

Wilson R, Welte T, Polverino E, De Soyza A, Greville H, O'Donnell A, Alder J, Reimnitz P, Hampel B.

Eur Respir J. 2013 May;41(5):1107-15. doi: 10.1183/09031936.00071312. Epub 2012 Sep 27.

20.

A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.

Gyssens IC, Dryden M, Kujath P, Nathwani D, Schaper N, Hampel B, Reimnitz P, Alder J, Arvis P.

J Antimicrob Chemother. 2011 Nov;66(11):2632-42. doi: 10.1093/jac/dkr344. Epub 2011 Sep 6.

21.

High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons.

Klöckener T, Hess S, Belgardt BF, Paeger L, Verhagen LA, Husch A, Sohn JW, Hampel B, Dhillon H, Zigman JM, Lowell BB, Williams KW, Elmquist JK, Horvath TL, Kloppenburg P, Brüning JC.

Nat Neurosci. 2011 Jun 5;14(7):911-8. doi: 10.1038/nn.2847.

22.

Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis.

Könner AC, Hess S, Tovar S, Mesaros A, Sánchez-Lasheras C, Evers N, Verhagen LA, Brönneke HS, Kleinridders A, Hampel B, Kloppenburg P, Brüning JC.

Cell Metab. 2011 Jun 8;13(6):720-8. doi: 10.1016/j.cmet.2011.03.021.

23.

Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans.

Bilkovski R, Schulte DM, Oberhauser F, Mauer J, Hampel B, Gutschow C, Krone W, Laudes M.

Int J Obes (Lond). 2011 Nov;35(11):1450-4. doi: 10.1038/ijo.2011.6. Epub 2011 Feb 1.

PMID:
21285942
24.

Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study.

Judlin P, Liao Q, Liu Z, Reimnitz P, Hampel B, Arvis P.

BJOG. 2010 Nov;117(12):1475-84. doi: 10.1111/j.1471-0528.2010.02687.x. Epub 2010 Aug 18.

25.

Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance.

Mauer J, Chaurasia B, Plum L, Quast T, Hampel B, Blüher M, Kolanus W, Kahn CR, Brüning JC.

PLoS Genet. 2010 May 6;6(5):e1000938. doi: 10.1371/journal.pgen.1000938.

26.

Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism.

Belgardt BF, Mauer J, Wunderlich FT, Ernst MB, Pal M, Spohn G, Brönneke HS, Brodesser S, Hampel B, Schauss AC, Brüning JC.

Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):6028-33. doi: 10.1073/pnas.1001796107. Epub 2010 Mar 15.

27.

Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance.

Bailly-Maitre B, Belgardt BF, Jordan SD, Coornaert B, von Freyend MJ, Kleinridders A, Mauer J, Cuddy M, Kress CL, Willmes D, Essig M, Hampel B, Protzer U, Reed JC, Brüning JC.

J Biol Chem. 2010 Feb 26;285(9):6198-207. doi: 10.1074/jbc.M109.056648. Epub 2009 Dec 7.

28.

Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity.

Ernst MB, Wunderlich CM, Hess S, Paehler M, Mesaros A, Koralov SB, Kleinridders A, Husch A, Münzberg H, Hampel B, Alber J, Kloppenburg P, Brüning JC, Wunderlich FT.

J Neurosci. 2009 Sep 16;29(37):11582-93. doi: 10.1523/JNEUROSCI.5712-08.2009.

29.

Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.

Solomkin J, Zhao YP, Ma EL, Chen MJ, Hampel B; DRAGON Study Team.

Int J Antimicrob Agents. 2009 Nov;34(5):439-45. doi: 10.1016/j.ijantimicag.2009.06.022. Epub 2009 Aug 18.

PMID:
19692210
30.

Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).

Weiss G, Reimnitz P, Hampel B, Muehlhofer E, Lippert H; AIDA Study Group.

J Chemother. 2009 Apr;21(2):170-80.

PMID:
19423470
31.

Central insulin action regulates peripheral glucose and fat metabolism in mice.

Koch L, Wunderlich FT, Seibler J, Könner AC, Hampel B, Irlenbusch S, Brabant G, Kahn CR, Schwenk F, Brüning JC.

J Clin Invest. 2008 Jun;118(6):2132-47. doi: 10.1172/JCI31073.

32.

PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response.

Belgardt BF, Husch A, Rother E, Ernst MB, Wunderlich FT, Hampel B, Klöckener T, Alessi D, Kloppenburg P, Brüning JC.

Cell Metab. 2008 Apr;7(4):291-301. doi: 10.1016/j.cmet.2008.01.006.

33.

Enhanced leptin-stimulated Pi3k activation in the CNS promotes white adipose tissue transdifferentiation.

Plum L, Rother E, Münzberg H, Wunderlich FT, Morgan DA, Hampel B, Shanabrough M, Janoschek R, Könner AC, Alber J, Suzuki A, Krone W, Horvath TL, Rahmouni K, Brüning JC.

Cell Metab. 2007 Dec;6(6):431-45.

34.

Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production.

Könner AC, Janoschek R, Plum L, Jordan SD, Rother E, Ma X, Xu C, Enriori P, Hampel B, Barsh GS, Kahn CR, Cowley MA, Ashcroft FM, Brüning JC.

Cell Metab. 2007 Jun;5(6):438-49.

35.

Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity.

Plum L, Ma X, Hampel B, Balthasar N, Coppari R, Münzberg H, Shanabrough M, Burdakov D, Rother E, Janoschek R, Alber J, Belgardt BF, Koch L, Seibler J, Schwenk F, Fekete C, Suzuki A, Mak TW, Krone W, Horvath TL, Ashcroft FM, Brüning JC.

J Clin Invest. 2006 Jul;116(7):1886-901. Epub 2006 Jun 22.

36.

Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence.

Hampel B, Fortschegger K, Ressler S, Chang MW, Unterluggauer H, Breitwieser A, Sommergruber W, Fitzky B, Lepperdinger G, Jansen-Dürr P, Voglauer R, Grillari J.

Exp Gerontol. 2006 May;41(5):474-81. Epub 2006 Apr 19.

PMID:
16626901
37.

Apoptosis resistance of senescent human fibroblasts is correlated with the absence of nuclear IGFBP-3.

Hampel B, Wagner M, Teis D, Zwerschke W, Huber LA, Jansen-Dürr P.

Aging Cell. 2005 Dec;4(6):325-30.

38.

Agouti-related peptide-expressing neurons are mandatory for feeding.

Gropp E, Shanabrough M, Borok E, Xu AW, Janoschek R, Buch T, Plum L, Balthasar N, Hampel B, Waisman A, Barsh GS, Horvath TL, Brüning JC.

Nat Neurosci. 2005 Oct;8(10):1289-91. Epub 2005 Sep 11.

PMID:
16158063
39.

Insulin-like growth factor-1 controls type 2 T cell-independent B cell response.

Baudler S, Baumgartl J, Hampel B, Buch T, Waisman A, Snapper CM, Krone W, Brüning JC.

J Immunol. 2005 May 1;174(9):5516-25.

40.

Differential regulation of apoptotic cell death in senescent human cells.

Hampel B, Malisan F, Niederegger H, Testi R, Jansen-Dürr P.

Exp Gerontol. 2004 Nov-Dec;39(11-12):1713-21.

PMID:
15582287
41.
42.

Senescence-associated cell death of human endothelial cells: the role of oxidative stress.

Unterluggauer H, Hampel B, Zwerschke W, Jansen-Dürr P.

Exp Gerontol. 2003 Oct;38(10):1149-60.

PMID:
14580868
43.

Metabolic stabilization of p27 in senescent fibroblasts correlates with reduced expression of the F-box protein Skp2.

Wagner M, Hampel B, Hütter E, Pfister G, Krek W, Zwerschke W, Jansen-Dürr P.

Exp Gerontol. 2001 Dec;37(1):41-55.

PMID:
11738146
44.

A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.

Schaberg T, Ballin I, Huchon G, Bassaris H, Hampel B, Reimnitz P; AECB Study Group.

J Int Med Res. 2001 Jul-Aug;29(4):314-28.

PMID:
11675905
45.

Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis.

Wagner M, Hampel B, Bernhard D, Hala M, Zwerschke W, Jansen-Dürr P.

Exp Gerontol. 2001 Aug;36(8):1327-47.

PMID:
11602208
46.

A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.

Siegert R, Gehanno P, Nikolaidis P, Bagger-Sjöbäck D, Ibanez JM, Hampel B, Sommerauer B.

Respir Med. 2000 Apr;94(4):337-44.

48.

Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report.

Hampel B, Hullmann R, Schmidt H.

Pediatr Infect Dis J. 1997 Jan;16(1):127-9; discussion 160-2. Review.

PMID:
9002122
49.

Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis.

Schaad UB, Wedgwood J, Ruedeberg A, Kraemer R, Hampel B.

Pediatr Infect Dis J. 1997 Jan;16(1):106-11; discussion 123-6.

PMID:
9002119
50.

Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles.

Claros MC, Citron DM, Hunt Gerardo S, Goldstein EJ, Schönian G, Montag T, Hampel B, Rodloff AC.

Clin Infect Dis. 1996 Dec;23 Suppl 1:S66-72.

PMID:
8953109

Supplemental Content

Loading ...
Support Center